HR Execs on the Move


 
For more than 235 years, Takeda has been serving society with innovative medicines, helping patients reclaim valuable moments of life from illness. Now, with new healthcare solutions from prevention to care and cure, we are determined to help even more people enjoy their lives to the fullest. Our mission is simple: we strive toward better health for patients worldwide through leading innovation in medicine. This mission: • Drives our research and development of prescription drugs • Promotes our commitment to social responsibility • Marks our growth and success At Takeda, our passion for healthcare and commitment to improving lives will ...
  • Number of Employees: 5K-10K
  • Annual Revenue: > $1 Billion
  • www.takeda.com
  • One Takeda Parkway
    Deerfield, IL USA 60015
  • Phone: 224.554.6500

Executives

Name Title Contact Details
Tuba Ertek
Global Head, HR Business Leader Profile
Heather Sepulveda
Head of Executive Search and Talent Profile
Mario Damo
CFO Takeda Oncology Profile
Paul Batten
Head of Global People Analytics at Takeda Profile
Jennifer Harnden-Koehler
Head of HR for Global Data Profile

Similar Companies

Pharmaceutical Buyers

Pharmaceutical Buyers is a Cedarhurst, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Institutional Pharmacy Solutions

Institutional Pharmacy Solutions is a Montgomery, AL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Euro Pharma

Euro Pharma is a Green Bay, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

major pharmaceuticals

major pharmaceuticals is a Livonia, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Spectrum Pharmaceuticals

Spectrum`s core mission is to bring pharmaceutical products to patients for unmet medical needs. To this mission, we bring our years of drug development expertise, coupled with the insight of working in many different oncology indications. Spectrum and its subsidiaries have six marketed oncology/hematology products, three for different types of non-Hodgkins lymphoma, one for advanced metastatic colorectal cancer, one for a certain type of acute lymphoblastic leukemia (ALL) and one for multiple myeloma. There are two products in late-stage development, as well as a broad and diversified portfolio of proprietary drugs in various stages of development, all with a focus on oncology and hematology.